Dana dhuwit diétung saben saham PolyPid (PYPD)

PolyPid Limited - logo grafis emiten PYPD

PolyPid Ltd. relies on clinical prospects as it awaits the completion of trials for new drugs. The cash position per share reflects current liquidity dynamics, where the parameter value equals 0.74. High efficiency is driven by an automated Israeli plant. Furthermore, the business possesses benchmark scalability potential, allowing it to generate colossal profits at low costs once the drugs are patented.

PYPD (PolyPid Ltd) riwayat Dana dhuwit saben saham saka 04.07.2022 nganti 20.11.2026

Rincian analitis perusahaan PolyPid Ltd (PYPD)

- rega saiki lan proyeksi nilai saham:
- indikator anane dhuwit lan arus kas:
Analisis komprehensif perusahaan:PolyPid (PYPD)
Produk merek PolyPid

The metric is calculated as the difference between net cash and total liabilities, divided by the number of shares. This metric determines the business's financial autonomy and its capacity for self-development without equity dilution. For PolyPid Ltd. (PYPD), this is critical during the commercialization of the D-PLEX drug and preparations for its market launch. The cash per share trend on GURU.Markets demonstrates the company's margin of safety before it reaches the stage of stable revenue.